Liudmila M. Krasnykh

Liudmila M. Krasnykh

Auto-generated profile, based on publicly available information

Liudmila M. Krasnykh

Scientific Centre for Expert Evaluation of Medicinal Products

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2019 in Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
OGO. A. Goroshko
O. A. Goroshko
LKL. M. Krasnykh
L. M. Krasnykh
VKV. G. Kukes
V. G. Kukes
VZV. I. Zozina
V. I. Zozina
The article examines the role of ubiquinone as a redox molecule whose functions consist in electron transport in the mitochondrial respiratory chain and regeneration of endogenous antioxidants. Changes in electron redox pathways cause uncontrolled release of reactive oxygen species, which leads to oxidative stress and development of pathologies. The objective of the study was to determine the content of coenzyme Q10 and its redox status in the human body as a biomarker of oxidative stress in various pathologies. This was achieved by assessing and consolidating data on changes in concentrations of the oxidized, reduced ubiquinone forms and total ubiquinone in various pathologies. Total serum ubiquinone was reduced in patients with chronic heart failure (0.68 μmol/L) compared with the control group (0.97 μmol/L). The redox status, expressed as the [ubiquinol]/ [ubiquinone] concentration ratio, decreased in patients with coronary heart disease (0.49 ± 0.34), diabetes (0.26 ± 0.16) compared with the healthy subjects (1.23–1.41). A negative correlation with malonic dialdehyde was observed. The authors analysed the possibility of assessing the efficacy of statin therapy by plasma ubiquinone concentration in patients. Patients with hyperlipidemia who received statins showed a statistically significant reduction in ubiquinol concentration after taking the drug (from 0.81 to 0.46 μg/mL) and the [ubiquinone]/[total ubiquinone] ratio (from 11 to 10 %), which confirms the potential mechanism of statinassociated muscle injury development. Thus, coenzyme Q10 redox status, as well as the concentrations of oxidized, reduced and total ubiquinone can be effective biomarkers of oxidative stress in cardiovascular diseases, diabetes, as well as an important indicator in evaluating the efficacy of hyperlipidemia treatment.

17 January 2022 in Pharmacokinetics and Pharmacodynamics
Verified
Journal Article
Open access
PDF file
VSValery Smirnov
Valery Smirnov
LKL. M. Krasnykh
L. M. Krasnykh
GRGalina Ramenskaya
Galina Ramenskaya
SKS. B. Kazanbekov
S. B. Kazanbekov
Relevance of the study: The quantification of endogenous substances is an important task in experimental and clinical pharmacology. In the case of working with endogenous compounds, certain difficulties arise. The main one is the impossibility of obtaining the same biomatrix without endogenous compounds for use as standard solutions in the construction of calibration curves. Purpose: The aim of our study was to develop a mathematical methodology for calculating the concentration of endogenous compounds in biological objects measured by chromatography, which allows us to obtain a statistically reliable interval estimation of the concentration of endogenous compounds. Materials and methods: To implement the computational part of the proposed algorithm, the Mathcad engineering calculation program version 15.0 from PTC (Parametric Technology Corporation) is used, which operates under the family of Windows operating systems (XP, 7, Vista, 8). Main results: A mathematical methodology has been developed for calculating the concentration of endogenous compounds in biological objects measured by chromatography, which allows one to obtain a statistically reliable interval estimate of the concentration of endogenous compounds. A feature of this technique is the use of an exclusively analyzed bioobject for quantitative determination of endogenous substances, without the use of so-called “pure” bioobjects for calibration curves, as well as expensive deuterated analogs of markers – substrates of CYP450 isoenzymes and their metabolites. This allows you to maintain the original biomatrix effect when removing the chromatogram. A statistical apparatus is also used to eliminate possible gross errors. To confirm the reliability of the developed method of quantitative determination, the convergence of the results obtained by this method using deuterated standards is established. Conclusions: A mathematical methodology has been developed for calculating the concentration of endogenous compounds in biological objects measured by chromatography, which allows one to obtain a statistically reliable interval estimate of the concentration of endogenous compounds. A feature of this technique is the use of only the analyzed bioobject for quantitative determination of endogenous substances, which allows you to maintain the original biomatrix effect when removing the chromatogram.

24 May 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
SSS. Yu. Serebrova
S. Yu. Serebrova
EKE. N. Kareva
E. N. Kareva
DKD. O. Kurguzova
D. O. Kurguzova
EDE. Yu. Demchenkova
E. Yu. Demchenkova
NENatalia Eremenko
Natalia Eremenko
APA. B. Prokofiev
A. B. Prokofiev
Helicobacter pylori infection can serve as one of indications to clarithromycin prescription. H. pylori eradication is performed commonly as a treatment for diseases caused by this pathogen and conditions with an increased risk of complications (precancerous changes of the gastric mucosa, unspecified iron deficiency anemia, idiopathic thrombocytopenic purpura, long-term NSAIDs use, anti-platelet drugs use etc). A number of H. pylori functional characteristics determines specific requirements for eradication schemes: high sensitivity of the pathogen, the ability of antibacterial drugs to penetrate and accumulate in gastric tissue and mucous,a stimulation of microorganism’s reproduction and protection of acid-resistant drugs by reducing gastric acid production as well. If the latter is provided by the use of proton pump inhibitors, then clarithromycin fully provides the other issues above. In Russia, standard triple therapy is used as the first-line treatment of H. pylori infection due to current clarithromycin resistance less than 15%. The article gives detailed reasoning and factual evidence of commitment to the first-line therapy under the increasing prevalence of the most recent antibiotic resistance (local resistance to levofloxacin has reached 20%), the high potential for multi-drug resistant H. pylori strains appearing, low ensuring medical facilities with relevant resistance test-systems, a role of generic drugs (clarithromycin and proton pump inhibitors) with compromised pharmaceutical characteristics in creation and erroneous interpretation of a pseudoresistance to clarithromycin.

12 July 2022 in Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
GVG. F. Vasilenko
G. F. Vasilenko
LKL. M. Krasnykh
L. M. Krasnykh
MZM. V. Zhuravleva
M. V. Zhuravleva
APA. B. Prokofiev
A. B. Prokofiev
GGG. I. Gorodetskaya
G. I. Gorodetskaya
NBN. D. Bunyatyan
N. D. Bunyatyan
The relationship between dissolution and bioavailability is an example of the interdependency between the quality of a medicinal product and its safety and efficacy. The uniqueness of thioctic acid is that it can exist in an oxidised and a reduced form, showing lipophilic (lipoic acid) and hydrophilic (dihydrolipoic acid) properties. Bioavailability studies of thioctic acid are necessary to evaluate the expected therapeutic effect and mitigate side effects of the medicinal product.The aim of the study was to carry out equivalence dissolution testing to compare the release of thioctic acid from medicinal products produced by several manufacturers.Materials and methods: the study used a reference medicinal product and three multisource medicinal products by different manufacturers; more specifically, film-coated tablets containing 600 mg of thioctic acid. The experiment was carried out in dissolution media at pH of 6.8±0.05 and 1.2±0.05. Statistical analysis was performed by calculating the average amounts of the substance dissolved, the standard deviation (SD), and the relative standard deviation (RSD, %) using Microsoft Office Excel 2007.Results: The authors chose the testing conditions (dissolution media pH values of 6.8±0.05 and 1.2±0.05) taking into account the nature and characteristics of thioctic acid. The comparison of thioctic acid release profiles based on the calculation of the similarity factor (f2) showed that the dissolution profiles of multisource medicinal products 2 and 3 at pH 6.8 were equivalent to that of the reference medicinal product (more than 85% of the active pharmaceutical ingredient released within 15 minutes) and the dissolution profile of multisource medicinal product 1 was not equivalent to it (with f2 of 28).Conclusions: the established differences in the rate and degree of active ingredient release from the studied medicinal products may indicate possible differences in their pharmacological effectiveness in vivo.

9 October 2020 in Russian Medicine
Verified
Journal Article
Open access
PDF file
LKLiudmila M. Krasnyk
Liudmila M. Krasnyk
OGOlga A. Goroshko
Olga A. Goroshko
DTDmitry V. Tsyganko
Dmitry V. Tsyganko
NBNadezhda Berdnikova
Nadezhda Berdnikova
VKViktoria G. Krasnyanskaya
Viktoria G. Krasnyanskaya
ЦВЦыганко Дмитрий Викторович
Цыганко Дмитрий Викторович
In patients with pneumonia and concomitant diseases, the administration of antimicrobial agents together with other medications accompanied by the risk of side effects and drug-drug interactions. We studied the pharmacokinetics (PK) of levofloxacin when combined with a herbal preparation (common St. Johns wort extract) in healthy volunteers and in patients with community-acquired pneumonia on the days 1 and 5 of the drugs intake. Individual differences in the average concentrations (AUC analog) of the antibiotic before and after the course of administration of the St. Johns wort extract within each group were quite significant; however, the group-average differences were statistically insignificant. Intergroup differences in PK with St. Johns wort intake were also statistically insignificant. To search for factors that make a significant contribution to the variations observed in PK indices, we used a statistical multivariate analysis of variance which included factors such as gender, age, body mass index, smoking history, and cardiovascular system parameters. We found that smoking only and, to a lesser extent, the patients gender had an effect on levofloxacin PK, while the intake of St. Johns wort completely eliminated this effect. Other factors played an insignificant role in the antibiotic PK regardless of the St. Johns wort administration.

19 August 2020 in Russian Medicine
Verified
Journal Article
Open access
PDF file
VSValery Smirnov
Valery Smirnov
LKL. M. Krasnykh
L. M. Krasnykh
GVG. F. Vasilenko
G. F. Vasilenko
GRGalina Ramenskaya
Galina Ramenskaya
OCO. A. Checha
O. A. Checha
This article analyzes the application of the method for determining the activity of CYP3A4 by determining the concentration of endogenous cholesterol and its metabolite/4-hydroxycholine in blood plasma. It also provides information on the convergence assessment of data obtained using alternative methods for determining the activity of the same CYP450 isoenzyme (CYP3A4) using different substrates: cholesterol and cortisol.